Published online July 1, 2008
PEDIATRICS Vol. 122 No. 1 July 2008, pp. 83-91 (doi:10.1542/peds.2007-2716)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjørke-Monsen, A.-L.
Right arrow Articles by Ueland, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjørke-Monsen, A.-L.
Right arrow Articles by Ueland, P. M.
Related Collections
Right arrow Nutrition & Metabolism
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Common Metabolic Profile in Infants Indicating Impaired Cobalamin Status Responds to Cobalamin Supplementation

Anne-Lise Bjørke-Monsen, MD, PhDa, Ingrid Torsvik, MDb, Hege Sætran, MDa, Trond Markestad, MD, PhDb and Per Magne Ueland, MD, PhDc

a Departments of Clinical Biochemistry
b Pediatrics, Haukeland University Hospital, Bergen, Norway
c Section for Pharmacology, Institute of Medicine, University of Bergen, Bergen, Norway

OBJECTIVE. A metabolic profile consistent with impaired cobalamin status is prevalent in breastfed infants. We investigated whether this profile reflects immature organ systems or impaired cobalamin status.

METHODS. In a single-center, randomized, placebo-controlled trial, we studied 107 six-week-old infants. The infants were randomly assigned to receive either an intramuscular injection of 400 µg of cobalamin or no intervention. Concentrations of cobalamin and folate in serum and total homocysteine, methylmalonic acid, and cystathionine in plasma were determined at enrollment and at the age of 4 months.

RESULTS. There were no significant differences between the intervention group (n = 54) and the control group (n = 53) in the concentrations of any vitamin marker at baseline (6 weeks). At 4 months, the supplement-treated infants had a 75% higher median serum cobalamin level and remarkable reductions in median plasma total homocysteine (from 7.46 to 4.57 µmol/L) and methylmalonic acid (from 0.58 to 0.20 µmol/L) levels, whereas levels of both metabolites were essentially unchanged during the follow-up period in the control group.

CONCLUSIONS. Cobalamin supplementation changed all markers of impaired cobalamin status (low cobalamin, high total homocysteine, and high methylmalonic acid levels) toward a profile observed in cobalamin-replete older children and adults. Therefore, the high total homocysteine and methylmalonic acid levels reported for a large fraction of infants reflect not immature metabolism but rather insufficient cobalamin levels to fully sustain cobalamin-dependent reactions fully.

Key Words: infant • breastfeeding • cobalamin deficiency • cobalamin supplementation

Abbreviations: tHcy—total homocysteine • MMA—methylmalonic acid


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 BMJ Case ReportsHome page
S. Agrawal and S. Nathani
Neuro-regression in vitamin B12 deficiency
BMJ Case Reports, March 17, 2009; 2009(mar08_1): bcr0620080235 - bcr0620080235.
[Abstract] [Full Text]